rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Nature's Sunshine Products, Inc.

NATR · Nasdaq

Health CareBiotechnologyNot moving yet

NATR stood above a rising 150-day average in 27 of the last 52 weekly readings, and has been out of that trend for the last 23 weeks. It is 35.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 23
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$5.2M
Insider sales, 12 months
$3.8M
Officials’ trades on record
0
Institutions holding
142 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 27 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$31.3M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months5
Sale orders, 12 months11
Buyers · sellers2 · 5
WhoDidSharesTraded
Prescott Group Capital Management, L.l.c.10% ownerbought20,000at $14.6917 Aug 2026filed 19 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought876at $15.6410 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought16,928at $15.8010 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought13,072at $15.7810 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought10,000at $16.0110 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought10,000at $16.467 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought1,000at $16.487 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought20,000at $16.557 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought5,000at $16.627 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought30,000at $16.687 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought20,000at $16.697 Aug 2026filed 10 Aug 2026
Prescott Group Capital Management, L.l.c.10% ownerbought10,000at $16.727 Aug 2026filed 10 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders142+1 on the quarter
New · exited17 · 17
Reported value$327.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
WYNNEFIELD CAPITAL INCunchanged · filed 14 Aug 20262,473,686$53.9M00.0%
Prescott Group Capital Management, L.L.C.unchanged · filed 7 Aug 20261,783,097$38.9M00.0%
BlackRock, Inc.reduced · filed 7 Aug 2026989,020$21.6M-75,434−7.1%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026923,626$20.1M+28,189+3.1%
AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026714,829$15.6M+140,004+24.4%
KENNEDY CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 2026623,831$13.6M-67,667−9.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026604,411$13.2M+7,578+1.3%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026527,568$11.5M-4,356−0.8%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026379,914$8.3M+7,365+2.0%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.unchanged · filed 14 Aug 2026340,000$7.4M00.0%
31 Mar 2023 – 30 Jun 2026
61100139Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Ruth Ann Perkins Company insiderEVP, Chief Financial Officer · last 2 Sep 20260 · 0
Jonathan David Lanoy Company insiderSVP, Chief Accounting Officer · last 1 Sep 20260 · 3
Phil Frohlich Company insider10% owner · last 17 Aug 20262 · 0
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Company insider10% owner · last 17 Aug 20264 · 1
Kevin R. Herbert Company insiderEVP & President, North America · last 26 Jun 20260 · 1
Bryant J. Yates Company insiderEVP & President, Europe · last 5 Jun 20260 · 13
Daniel C. Norman Company insiderEVP & President, Asia · last 1 Jun 20260 · 13
Nathan G. Brower Company insiderEVP, General Counsel · last 21 May 20260 · 7
Curtis Kopf Company insiderDirector · last 15 May 20260 · 0
Erich A. Fritz Company insiderEVP, Global Supply Chain · last 15 May 20260 · 0
Heidi Wissmiller Company insiderDirector · last 15 May 20260 · 0
Katie May Company insiderDirector · last 15 May 20260 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202572.4%
Operating profit marginFY 2025 · to 31 Dec 20255.2%
Free cash flow marginFY 2025 · to 31 Dec 20256.0%
Return on capital employedFY 2025 · to 31 Dec 202513.5%
Cash conversionFY 2025 · to 31 Dec 2025181%
Research spendFY 2025 · to 31 Dec 20250.4%
Share count trendFY 2025 · to 20 Feb 2026-0.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$93.9M
Free cash flowFY 2025 · to 31 Dec 2025$28.8M

Analyst forecasts

No analyst forecasts yet.